Daniel Emerling

No open positions remaining

Health Technology

Finance

Consumer Services

Profile

Daniel Emerling was the founder of Atreca, Inc., founded in 2010, serving as Senior Vice President-Research from 2010 to 2022.
Former jobs include Senior Director-Preclinical Pharmacology at Renovis, Inc. from 2000 to 2009 and Senior Director-Pharmacology at Nuon Therapeutics, Inc. from 2010 to 2011.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.

Former positions of Daniel Emerling

Companies	Position	End
ATRECA, INC.	Founder	01/10/2022
Nuon Therapeutics, Inc. Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases	Corporate Officer/Principal	01/01/2011
Renovis, Inc. Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Corporate Officer/Principal	01/01/2009

See the detail of Daniel Emerling's experience

Training of Daniel Emerling

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Emerling's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Renovis, Inc. Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Atreca, Inc. Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers	Health Technology
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nuon Therapeutics, Inc. Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases	Health Technology